"Medical Research"

During the past decade, Advantage Clinical Trials conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advantage Clinical Trials" #1 sponsor was "Celgene" with 3 trials, followed by "Allergan" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored and "NeuroBo Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advantage Clinical Trials" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Advantage Clinical Trials" are "Crohn Disease" (3 trials), "Cold Sore" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Functional Constipation" (1 trials) and "Gastroesophageal Reflux Disease (GERD)" (1 trials). Many other conditions were trialed in "Advantage Clinical Trials" in a lesser frequency.

Most popular intervention types in "Advantage Clinical Trials" are "Drug" (8 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advantage Clinical Trials" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Advantage Clinical Trials". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Advantage Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advantage Clinical Trials, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".